🔎 Trials Near Me

Início › Leucemia Mieloide Aguda › Geórgia › Atlanta

Ensaios clínicos de Leucemia Mieloide Aguda em Atlanta, GA

31 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Atlanta e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.

Texto oficial do estudo (Inglês)

Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

RecrutandoFase 1
  • Children'S Healthcare Of Atlanta - Arthur M. Blank Hospital /ID# 275740, Atlanta
6 Months – 17 Years · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT07306832

Ivosidenib as Post-HSCT Maintenance for AML

RecrutandoFase 2
  • Emory University Hospital, Atlanta
Idades de 18 a 75 · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06707493

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

RecrutandoFase 1
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Até 21 anos · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT07012044

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

RecrutandoFase 2/3
  • Winship Cancer Institute of Emory University /ID# 279006, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07581002

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Atlanta VA Medical Center, Decatur · a 6 mi de distância
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecrutandoEstudo observacional
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Idades de 0 a 38 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06131801

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

RecrutandoFase 1
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

RecrutandoFase 1
  • Emory University, Atlanta
Idades de 12 a 78 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecrutandoFase 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
6 Months – 21 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RecrutandoFase 1/2
  • Emory Winship Cancer Institute, Atlanta
30 Days · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT04065399

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RecrutandoFase 2
  • Winship Cancer Institute - Emory University, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04996875

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

RecrutandoFase 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Idades de 1 a 25 · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07022678

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

RecrutandoFase 3
  • US-Atlanta GA-EMORY, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

RecrutandoFase 3
  • US-Atlanta GA-EMORY, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07223814

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RecrutandoFase 1/2
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RecrutandoFase 3
  • Children's Healthcare of Atlanta, Atlanta
29 Days – 21 Years · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecrutandoFase 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT06001788

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RecrutandoFase 1
  • Children's Healthcare of Atlanta, Atlanta
Idades de 1 a 30 · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT06177067

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

RecrutandoFase 1Voluntários saudáveis bem-vindos
  • Northside Hospital, Atlanta
Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT07020533

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RecrutandoFase 3
  • Emory University - Winship Cancer Institute (WCI), Atlanta
Idades de 18 a 75 · Todos os sexos · Atualizado em 17 de jul. de 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecrutandoEstudo observacional
  • Children's Healthcare of Atlanta, Atlanta
  • Northside Hospital, Atlanta
Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

RecrutandoFase 1/2
  • Emory Winship Cancer Institute, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 24 de jun. de 2026 · NCT04068597

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

RecrutandoFase 1
  • Winship Cancer Institute / Emory University, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jun. de 2026 · NCT05768932

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

RecrutandoFase 2/3
  • University of Emory - Winship Cancer Institute, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT04256317

Pilot Imaging Study of Leukemia

RecrutandoFase 1
  • Emory University, Atlanta
Idades de 4 a 80 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT03633955

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecrutandoFase 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 13 de mar. de 2026 · NCT05735184

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

RecrutandoFase 2Voluntários saudáveis bem-vindos
  • Northside Hospital, Atlanta
Idades de 18 a 75 · Todos os sexos · Atualizado em 10 de mar. de 2026 · NCT06059391

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

RecrutandoFase 1
  • Emory University Hospital, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jan. de 2026 · NCT05143996

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

RecrutandoFase 1
  • Emory University - WINSHIP Cancer Center, Atlanta
  • Emory University, Children's Healthcare of Atlanta, Atlanta
Idades 12 e acima · Todos os sexos · Atualizado em 8 de jan. de 2026 · NCT04872478

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecrutandoFase 1
  • Blood and Marrow Transplant Group of Georgia, Atlanta
Idades 18 e acima · Todos os sexos · Atualizado em 31 de out. de 2025 · NCT06549790

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

RecrutandoVoluntários saudáveis bem-vindos
  • Emory University, Atlanta
Idades de 18 a 120 · Todos os sexos · Atualizado em 25 de jul. de 2025 · NCT05237258

Ensaios de Leucemia Mieloide Aguda em outras cidades

Outros estudos em Atlanta

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.